← FDA DRUG APPROVALS

FDA ANDA · ANDA073054

DOXEPIN HYDROCHLORIDE

Sponsor: PUREPAC PHARM

APPLICATION
ANDA073054
TYPE
ANDA
ORIGINAL APPROVAL
1990-12-28
LATEST ACTION
1991-03-26
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

DOXEPIN HYDROCHLORIDEDiscontinued
DOXEPIN HYDROCHLORIDE EQ 10MG BASE · CAPSULE · ORAL

Approval history

1991-03-26Labeling · Supplement 1AP
1990-12-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →